Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,700,331 | $2,207,216 | $2,341,820 | $2,749,258 |
| - Cash | $183,049 | $201,373 | $210,437 | $221,403 |
| + Debt | $75,572 | $78,150 | $80,298 | $82,616 |
| Enterprise Value | $1,592,854 | $2,083,993 | $2,211,681 | $2,610,471 |
| Revenue | $99,009 | $96,057 | $92,793 | $88,713 |
| % Growth | 3.1% | 3.5% | 4.6% | – |
| Gross Profit | $50,837 | $51,297 | $46,028 | $42,840 |
| % Margin | 51.3% | 53.4% | 49.6% | 48.3% |
| EBITDA | -$20,878 | $26,381 | -$32,606 | -$25,093 |
| % Margin | -21.1% | 27.5% | -35.1% | -28.3% |
| Net Income | -$27,138 | $20,390 | -$39,328 | -$31,594 |
| % Margin | -27.4% | 21.2% | -42.4% | -35.6% |
| EPS Diluted | -0.45 | 0.33 | -0.66 | -0.53 |
| % Growth | -236.4% | 150% | -24.5% | – |
| Operating Cash Flow | -$11,814 | -$1,400 | -$12,986 | -$21,428 |
| Capital Expenditures | -$12,427 | -$9,165 | -$4,144 | -$2,268 |
| Free Cash Flow | -$24,241 | -$10,565 | -$17,130 | -$23,696 |